Monitoring the health to disease continuum with global metabolic profiling and systems biology

被引:67
作者
Schnackenberg, Laura K. [1 ]
Beger, Richard D. [1 ]
机构
[1] US FDA, Natl Ctr Toxicol Res, Div Syst Toxicol, Jefferson, AR 72079 USA
关键词
metabolic profiling; metabonomics; metabolomics; systems biology;
D O I
10.2217/14622416.7.7.1077
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Global metabolic profiling, which includes both metabolomics and metabonomics studies, is the latest 'omics' research platform that is being applied to understand the health and disease continuum. Metabolic profiling analyses have been demonstrated for the investigation of inborn errors of metabolism, organ transplant rejection, drug toxicity, disease diagnosis and prognosis, drug efficacy and nutritional status. Combining information generated from a metabolic profiling platform with that obtained based on genetics, transcriptomics and proteomics research paradigms will pave the way for a better understanding of the mechanisms of disease and toxicity. Metabolomics and nutrition will lay the groundwork for the application of personalized medicine in the 21st century.
引用
收藏
页码:1077 / 1086
页数:10
相关论文
共 92 条
  • [1] Nutrition-/diet-induced changes in gene expression in white adipose tissue
    Al-Hasani, H
    Joost, HG
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 19 (04) : 589 - 603
  • [2] Medium-chain Acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-Based prospective screening of newborns differ from those observed in patients with clinical symptoms: Identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency
    Andresen, BS
    Dobrowolski, SF
    O'Reilly, L
    Muenzer, J
    McCandless, SE
    Frazier, DM
    Udvari, S
    Bross, P
    Knudsen, I
    Banas, R
    Chace, DH
    Engel, P
    Naylor, EW
    Gregersen, N
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (06) : 1408 - 1418
  • [3] Batch statistical processing of 1H NMR-derived urinary spectral data
    Antti, H
    Bollard, ME
    Ebbels, T
    Keun, H
    Lindon, JC
    Nicholson, JK
    Holmes, E
    [J]. JOURNAL OF CHEMOMETRICS, 2002, 16 (8-10) : 461 - 468
  • [4] Metabolomic approaches to mitochondrial disease: correlation of urine organic acids
    Barshop, BA
    [J]. MITOCHONDRION, 2004, 4 (5-6) : 521 - 527
  • [5] BEGER RD, 2006, METABOLOMICS
  • [6] NUCLEAR-MAGNETIC-RESONANCE STUDIES OF BLOOD-PLASMA AND URINE FROM SUBJECTS WITH CHRONIC-RENAL-FAILURE - IDENTIFICATION OF TRIMETHYLAMINE-N-OXIDE
    BELL, JD
    LEE, JA
    LEE, HA
    SADLER, PJ
    WILKIE, DR
    WOODHAM, RH
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1096 (02) : 101 - 107
  • [7] Paracetamol (acetaminophen)-induced toxicity: Molecular and biochemical mechanisms, analogues and protective approaches
    Bessems, JGM
    Vermeulen, NPE
    [J]. CRITICAL REVIEWS IN TOXICOLOGY, 2001, 31 (01) : 55 - 138
  • [8] Large-scale human metabolomics studies: A strategy for data (pre-) processing and validation
    Bijlsma, S
    Bobeldijk, L
    Verheij, ER
    Ramaker, R
    Kochhar, S
    Macdonald, IA
    van Ommen, B
    Smilde, AK
    [J]. ANALYTICAL CHEMISTRY, 2006, 78 (02) : 567 - 574
  • [9] [1,2-13C2]-D-glucose profiles of the serum, liver, pancreas, and DMBA-induced pancreatic tumors of rats
    Boros, LG
    Lerner, MR
    Morgan, DL
    Taylor, SL
    Smith, BJ
    Postier, RG
    Brackett, DJ
    [J]. PANCREAS, 2005, 31 (04) : 337 - 343
  • [10] Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802